Prep Biopharm

Developing RNA based immunomodulators for the prevention of respiratory infections

placeLondon, England, United Kingdom calendar_todayFounded 2015 groups118 employees language prepbiopharm.com

Registered entities

Investor mix

20 investors on record; lead investors include hVIVO, Johnson & Johnson Innovation.

Investor typeCountShare
Other / undisclosed20100%
Coming soon